These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4399996)

  • 21. The influence of in vivo administration of dimethyl sulfoxide on the in vitro metabolism of some monocyclic aromatic chemicals by hepatic microsomal preparations.
    Stock BH; Fouts JR
    Toxicol Appl Pharmacol; 1971 Apr; 18(4):859-68. PubMed ID: 5570238
    [No Abstract]   [Full Text] [Related]  

  • 22. Acute interaction of drugs. I. The effect of volatile anesthetics on the kinetics of aniline hydroxylase and aminopyrine demethylase in rat hepatic microsomes.
    Korten K; Van Dyke RA
    Biochem Pharmacol; 1973 Sep; 22(17):2105-12. PubMed ID: 4733666
    [No Abstract]   [Full Text] [Related]  

  • 23. Response of the mixed function oxidase system of rat hepatic microsomes to parathion and malathion and their oxygenated analogs.
    Stevens JT; Greene FE
    Life Sci; 1973 Dec; 13(12):1677-91. PubMed ID: 4149666
    [No Abstract]   [Full Text] [Related]  

  • 24. Reduced nicotinamide adenine dinucleotide phosphate (NADPH)-dependent formation and breakdown of hydrogen peroxide during mixed function oxidation reactions in liver microsomes.
    Hildebraunt AG; Roots I
    Arch Biochem Biophys; 1975 Dec; 171(2):385-97. PubMed ID: 955
    [No Abstract]   [Full Text] [Related]  

  • 25. Polychlorinated naphthalenes as hepatic microsomal enzyme inducers in the immature male rat.
    Cockerline R; Shilling M; Safe S
    Gen Pharmacol; 1981; 12(2):83-7. PubMed ID: 7202998
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of linoleic acid hydroperoxide on the hepatic monooxygenase systems of microsomes from untreated, phenobarbital-treated, and 3-methylcholanthrene-treated rats.
    Jeffery E; Kotake A; Azhary RE
    Mol Pharmacol; 1977 May; 13(3):415-25. PubMed ID: 406515
    [No Abstract]   [Full Text] [Related]  

  • 27. Kinetic changes in microsomal drug metabolism with age and diphenylhydantoin treatment.
    Eling TE; Harbison RD; Becker BA; Fouts JR
    Eur J Pharmacol; 1970 Jul; 11(1):101-8. PubMed ID: 4393448
    [No Abstract]   [Full Text] [Related]  

  • 28. Structural properties of rough and smooth microsomal membranes. A study with fluorescence probes.
    Dallner G; Azzi A
    Biochim Biophys Acta; 1972 Feb; 255(2):589-601. PubMed ID: 5057936
    [No Abstract]   [Full Text] [Related]  

  • 29. Conversion of naphthalene to trans-naphthalene dihydrodiol: evidence for the presence of a coupled aryl monooxygenase-epoxide hydrase system in hepatic microsomes.
    Oesch F; Daly J
    Biochem Biophys Res Commun; 1972 Feb; 46(4):1713-20. PubMed ID: 5015607
    [No Abstract]   [Full Text] [Related]  

  • 30. Inhibition by deuterated water of the mixed-function oxidases of hepatic microsomes of the male rat.
    Holtzman JL; Carr ML
    Mol Pharmacol; 1972 Sep; 8(5):481-9. PubMed ID: 4404332
    [No Abstract]   [Full Text] [Related]  

  • 31. Influence of pyridine and some pyridine derivatives on spectral properties of reduced microsomes and on microsomal drug metabolizing activity.
    Jonen HG; Hüthwohl B; Kahl R; Kahl GF
    Biochem Pharmacol; 1974 Apr; 23(8):1319-29. PubMed ID: 4824776
    [No Abstract]   [Full Text] [Related]  

  • 32. Reduced diphosphopyridine nucleotide synergism of the reduced triphosphopyridine nucleotide-dependent mixed-function oxidase system of hepatic microsomes. II. Role of the type I drug-binding site of cytochrome P-450.
    Correia MA; Mannering GJ
    Mol Pharmacol; 1973 Jul; 9(4):470-85. PubMed ID: 4146890
    [No Abstract]   [Full Text] [Related]  

  • 33. Toxicological implications of the mixed-function oxidase catalyzed metabolism of carbon disulfide.
    Dalvi RR; HUNTER AL; Neal RA
    Chem Biol Interact; 1975 May; 10(5):347-61. PubMed ID: 237636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolism of naphthalene to naphthalene dihydrodiol glucuronide in isolated hepatocytes and in liver microsomes.
    Bock KW; van Ackeren G; Lorch F; Birke FW
    Biochem Pharmacol; 1976 Nov; 25(21):2351-6. PubMed ID: 826255
    [No Abstract]   [Full Text] [Related]  

  • 35. Benzpyrene pretreatment changes the kinetics and pH optimum for aniline hydroxylation in vitro, but not those for benzphetamine demethylation in vitro by rat liver microsomes.
    Rickert DE; Fouts JR
    Biochem Pharmacol; 1970 Feb; 19(2):381-90. PubMed ID: 5507656
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunochemical studies on the role of reduced nicotinamide adenine dinucleotide phosphate-cytochrome c (P-450) reductase in drug oxidation.
    Glazer RI; Schenkman JB; Sartorelli AC
    Mol Pharmacol; 1971 Nov; 7(6):683-8. PubMed ID: 4402120
    [No Abstract]   [Full Text] [Related]  

  • 37. Species differences in stimulation of intestinal and hepatic microsomal mixed-function oxidase enzymes.
    Miranda CL; Chhabra RS
    Biochem Pharmacol; 1980 Apr; 29(8):1161-5. PubMed ID: 7387731
    [No Abstract]   [Full Text] [Related]  

  • 38. A comparison of the effects of halothane and CCl 4 on the hepatic drug metabolizing system.
    Davis DC; Schroeder DH; Gram TE; Reagan RL; Gillette JR
    J Pharmacol Exp Ther; 1971 Jun; 177(3):556-66. PubMed ID: 4398189
    [No Abstract]   [Full Text] [Related]  

  • 39. The interaction of the antineoplastic drug thalicarpine with aniline hydroxylase and microsomal cytochrome of rat liver.
    Creaven PJ; Allen LM; Williams CP
    Xenobiotica; 1974 Apr; 4(4):255-61. PubMed ID: 4152572
    [No Abstract]   [Full Text] [Related]  

  • 40. Ascorbic acid and drug metabolism.
    Zannoni VG; Flynn EJ; Lynch M
    Biochem Pharmacol; 1972 May; 21(10):1377-92. PubMed ID: 4402218
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.